Nodelman Oleg's Form 4 filing
Anaptysbio, Inc (ANAB) · filed Jan 2, 2025
- Accession no.
- 0000935836-25-000008
- Filed
- Jan 2, 2025, 6:17 PM ET
- Trade date
- Dec 30, 2024-Jan 2, 2025
- Filing delay
- 3 days
- Rule 10b5-1 plan
- Not checked
This filing lists 3 non-derivative transactions and 0 derivative transactions. Open-market purchases total $1.10M. It was filed 3 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Nodelman OlegCIK 0001454385 | Director, 10% Owner |
| EcoR1 Capital, LLCCIK 0001587114 | Director, 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 30, 2024 | Common Stock | PPurchaseAcquired | +65,184 | $12.92 | +$842,059.95 | 7,860,180 | Indirect | |
| Dec 31, 2024 | Common Stock | PPurchaseAcquired | +13,268 | $12.93 | +$171,512.78 | 7,873,448 | Indirect | |
| Jan 2, 2025 | Common Stock | PPurchaseAcquired | +6,646 | $12.95 | +$86,069.69 | 7,880,094 | Indirect |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.